← All organizations

Wockhardt

For profitWebsite ↗

Also known as: Wockhardt | WOCKHARDT | WOCKHARDT BIO AG | WOCKHARDT EU OPERATN | Wockhardt Ltd | WOCKHARDT LTD | WOCKHARDT USA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

May 29, 2026

Timeline

1990s

Jun 1, 1999
Wockhardt— Founded

2000s

Jul 9, 2003
Cp Pharma— Acquired
Dec 30, 2004
pregabalin— NDA Secondary Org
Oct 4, 2006
Pinewood Laboratories— Acquired
May 18, 2007
Laboratoires NEGMA— Acquired
Oct 23, 2007
Morton Grove Pharmaceuticals— Acquired

2010s

Aug 10, 2012
alfuzosin— Marketing Organization

Drugs by trial phase (18 distinct, 41 trials)

Phase 4 (0 own, 1 via acquisition)

diacerein

Phase 3 (9 own, 1 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (4 direct, 4 total across the full acquisition tree)

Recent trials (47)

NCT06806995Lead sponsorPhase 1Jan 21, 2025
NCT04979806Lead sponsorPhase 3Jan 31, 2022
NCT04979806Study directorPhase 3Jan 31, 2022
NCT03981887Lead sponsorPhase 1Jun 17, 2019
NCT03630081Lead sponsorPhase 3Aug 25, 2018
NCT03630081Study directorPhase 3Aug 25, 2018
NCT03622008Lead sponsorPhase 1Mar 23, 2018
NCT07247942Lead sponsorPhase 1Dec 13, 2017
NCT03405064Lead sponsorPhase 3Aug 25, 2017
NCT03405064Study directorPhase 3Aug 25, 2017
NCT03630094Lead sponsorPhase 1Mar 31, 2017
NCT03554304Lead sponsorPhase 1Feb 9, 2017
NCT02942810Lead sponsorPhase 1Oct 1, 2016
NCT02903836Study directorPhase 2Sep 1, 2016
NCT02903836Lead sponsorPhase 2Sep 1, 2016

Details

Founded: Mumbai, IN Jun 1, 1999
Last known activity: May 29, 2026